nach oben

NeuroMolecular Medicine

Erschienen in:

12.06.2021 | Original Paper

Revealing the Modular Similarities and Differences Among Alzheimer’s Disease, Vascular Dementia, and Parkinson’s Disease in Genomic Networks

verfasst von: Yafei Chen, Qiong Liu, Jun Liu, Penglu Wei, Bing Li, Nongyun Wang, Zhenquan Liu, Zhong Wang

Erschienen in: NeuroMolecular Medicine | Ausgabe 2/2022

Einloggen, um Zugang zu erhalten

Abstract

Alzheimer’s disease (AD), vascular dementia (VD), and Parkinson’s disease (PD) exert increasingly lethal or disabling effects on humans, but the associations among these diseases at the molecular level remain unclear. In our research, lists of genes related to these three diseases were acquired from public databases. We constructed gene–gene networks of the lists of disease-related genes using the STRING database and selected the plug-in MCODE as the most suitable method to divide the three disease-associated networks into modules through an entropy calculation. Notably, 1173 AD-related, 203 VD-related, and 722 PD-related genes as well as 72 overlapping genes were observed among the three diseases. By dividing the modules from the gene network, we divided the AD-related gene network into 27 modules, the VD-related gene network into 8 modules, and the PD-related gene network into 17 modules. After the enrichment analysis of each disease-related gene, 146 overlapping biological processes and 32 overlapping pathways were identified. Ultimately, through similarity analysis of the genes, biological processes, and pathways, we found that AD and VD were the most closely related at the biological process and pathway levels, with similarity coefficients of 0.2784 and 0.3626, respectively. After analyzing the overlapping gene network, we found that INS might play an important role in the network and that insulin and its signaling pathways may play a key role in these neurodegenerative diseases. Our research illustrates a new method for in-depth research on the three diseases, which may accelerate the progress of developing new therapeutics and may be applied to prevent neurodegenerative diseases.

Nur mit Berechtigung zugänglich

Anang, J. B., Nomura, T., Romenets, S. R., Nakashima, K., Gagnon, J. F., & Postuma, R. B. (2017). Dementia predictors in parkinson disease: A validation study. Journal of Parkinson’s Disease, 7(1), 159–162. https://doi.org/10.3233/JPD-160925CrossRefPubMed

Ashburner, M., Ball, C. A., Blake, J. A., Botstein, D., Butler, H., Cherry, J. M., Davis, A. P., Dolinski, K., Dwight, S. S., Eppig, J. T., Harris, M. A., Hill, D. P., Issel-Tarver, L., Kasarskis, A., Lewis, S., Matese, J. C., Richardson, J. E., Ringwald, M., Rubin, G. M., & Sherlock, G. (2000). Gene ontology: Tool for the unification of biology. The gene ontology consortium. Nature Genetics, 25(1), 25–29. https://doi.org/10.1038/75556CrossRefPubMedPubMedCentral

Ashraf, G. M., Chibber, S., Mohammad, Zaidi, S. K., Tabrez, S., Ahmad, A., Shakil, S., Mushtaq, G., Baeesa, S. S., & Kamal, M. A. (2016). Recent updates on the association between Alzheimer's disease and vascular dementia. Medicinal Chemistry (Shariqah (United Arab Emirates)), 12(3), 226–237. https://doi.org/10.2174/1573406411666151030111820CrossRef

Bader, G. D., & Hogue, C. W. (2003). An automated method for finding molecular complexes in large protein interaction networks. BMC Bioinformatics, 4, 2. https://doi.org/10.1186/1471-2105-4-2CrossRefPubMedPubMedCentral

Barabási, A. L., Gulbahce, N., & Loscalzo, J. (2011). Network medicine: A network-based approach to human disease. Nature Reviews Genetics, 12(1), 56–68. https://doi.org/10.1038/nrg2918CrossRefPubMedPubMedCentral

Ben-Hamouda, I., Tougourti, M. N., & Hamza, M. (2002). Hypertrophic cardiomyopathy: a rare cause of vascular dementia. A case report. La Tunisie medicale, 80(7), 420–423.PubMed

Benn, M., Nordestgaard, B. G., Frikke-Schmidt, R., & Tybjærg-Hansen, A. (2017). Low LDL cholesterol, PCSK9 and HMGCR genetic variation, and risk of Alzheimer’s disease and Parkinson’s disease: Mendelian randomisation study. BMJ (clinical Research Ed.), 357, j1648. https://doi.org/10.1136/bmj.j1648CrossRef

Bisht, I., Ambasta, R. K., & Kumar, P. (2020). An integrated approach to unravel a putative crosstalk network in Alzheimer’s disease and Parkinson’s disease. Neuropeptides, 83, 102078. https://doi.org/10.1016/j.npep.2020.102078CrossRefPubMed

Brohée, S., & van Helden, J. (2006). Evaluation of clustering algorithms for protein-protein interaction networks. BMC Bioinformatics, 7, 488. https://doi.org/10.1186/1471-2105-7-488CrossRefPubMedPubMedCentral

Brown, G. R., Hem, V., Katz, K. S., Ovetsky, M., Wallin, C., Ermolaeva, O., Tolstoy, I., Tatusova, T., Pruitt, K. D., Maglott, D. R., & Murphy, T. D. (2015). Gene: a gene-centered information resource at NCBI. Nucleic Acids Research, 43(Database issue), D36–D42. https://doi.org/10.1093/nar/gku1055CrossRefPubMed

Bubniene, U., Mazetyte, R., Ramanaviciene, A., Gulbinas, V., Ramanavicius, A., & Karpicz, R. (2018). Fluorescence quenching-based evaluation of glucose oxidase composite with conducting polymer, polypyrrole. The Journal of Physical Chemistry C, 122(17), 9491–9498. https://doi.org/10.1021/acs.jpcc.8b01610CrossRef

Cenini, G., Lloret, A., & Cascella, R. (2019). Oxidative stress in neurodegenerative diseases: From a mitochondrial point of view. Oxidative Medicine and Cellular Longevity, 2019, 2105607. https://doi.org/10.1155/2019/2105607CrossRefPubMedPubMedCentral

Chen, Y. Y., Yu, Y. N., Zhang, Y. Y., Li, B., Liu, J., Li, D. F., Wu, P., Wang, J., Wang, Z., & Wang, Y. Y. (2016). Quantitative determination of flexible pharmacological mechanisms based on topological variation in mice anti-ischemic modular networks. PLoS ONE, 11(7), e0158379. https://doi.org/10.1371/journal.pone.0158379CrossRefPubMedPubMedCentral

Cheung, C., Chang, Y. C., Lin, T. Y., Cheng, S. M., & Leung, E. (2020). Anti-apoptotic proteins in the autophagic world: An update on functions of XIAP, Survivin, and BRUCE. Journal of Biomedical Science, 27(1), 31. https://doi.org/10.1186/s12929-020-0627-5CrossRefPubMedPubMedCentral

Dennis, G., Jr., Sherman, B. T., Hosack, D. A., Yang, J., Gao, W., Lane, H. C., & Lempicki, R. A. (2003). DAVID: Database for annotation, visualization, and integrated discovery. Genome Biology, 4(5), P3.CrossRef

Eckl-Dorna, J., Villazala-Merino, S., Campion, N. J., Byazrova, M., Filatov, A., Kudlay, D., Karsonova, A., Riabova, K., Khaitov, M., Karaulov, A., Niederberger-Leppin, V., & Valenta, R. (2019). Tracing IgE-producing cells in allergic patients. Cells, 8(9), 994. https://doi.org/10.3390/cells8090994CrossRefPubMedCentral

Fischer, R., & Maier, O. (2015). Interrelation of oxidative stress and inflammation in neurodegenerative disease: Role of TNF. Oxidative Medicine and Cellular Longevity, 2015, 610813. https://doi.org/10.1155/2015/610813CrossRefPubMedPubMedCentral

Franco, R., Navarro, G., & Martínez-Pinilla, E. (2019). Lessons on differential neuronal-death-vulnerability from familial cases of Parkinson’s and Alzheimer’s diseases. International Journal of Molecular Sciences, 20(13), 3297. https://doi.org/10.3390/ijms20133297CrossRefPubMedCentral

Ganguly, G., Chakrabarti, S., Chatterjee, U., & Saso, L. (2017). Proteinopathy, oxidative stress and mitochondrial dysfunction: Cross talk in Alzheimer’s disease and Parkinson’s disease. Drug Design, Development and Therapy, 11, 797–810. https://doi.org/10.2147/DDDT.S130514CrossRefPubMedPubMedCentral

Guzman-Martinez, L., Maccioni, R. B., Andrade, V., Navarrete, L. P., Pastor, M. G., & Ramos-Escobar, N. (2019). Neuroinflammation as a common feature of neurodegenerative disorders. Frontiers in Pharmacology, 10, 1008. https://doi.org/10.3389/fphar.2019.01008CrossRefPubMedPubMedCentral

Han, J. D., Bertin, N., Hao, T., Goldberg, D. S., Berriz, G. F., Zhang, L. V., Dupuy, D., Walhout, A. J., Cusick, M. E., Roth, F. P., & Vidal, M. (2004). Evidence for dynamically organized modularity in the yeast protein-protein interaction network. Nature, 430(6995), 88–93. https://doi.org/10.1038/nature02555CrossRefPubMed

Hou, Y., Dan, X., Babbar, M., Wei, Y., Hasselbalch, S. G., Croteau, D. L., & Bohr, V. A. (2019). Ageing as a risk factor for neurodegenerative disease. Nature Reviews Neurology, 15(10), 565–581. https://doi.org/10.1038/s41582-019-0244-7CrossRefPubMed

Jaccard, P. (1912). The distribution of the flora in the alpine zone.1. New Phytologist, 11, 37–50. https://doi.org/10.1111/j.1469-8137.1912.tb05611.xCrossRef

Jones, M. K., Nair, A., & Gupta, M. (2019). Mast cells in neurodegenerative disease. Frontiers in Cellular Neuroscience, 13, 171. https://doi.org/10.3389/fncel.2019.00171CrossRefPubMedPubMedCentral

Juul-Rasmussen, I., Tybjærg-Hansen, A., Rasmussen, K. L., Nordestgaard, B. G., & Frikke-Schmidt, R. (2019). Blood-brain barrier transcytosis genes, risk of dementia and stroke: A prospective cohort study of 74,754 individuals. European Journal of Epidemiology, 34(6), 579–590. https://doi.org/10.1007/s10654-019-00498-2CrossRefPubMedPubMedCentral

Kanehisa, M., & Goto, S. (2000). KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Research, 28(1), 27–30. https://doi.org/10.1093/nar/28.1.27CrossRefPubMedPubMedCentral

Kelly, J., Moyeed, R., Carroll, C., Luo, S., & Li, X. (2020). Genetic networks in Parkinson's and Alzheimer's disease. Aging, 12(6):5221–5243. https://doi.org/10.18632/aging.102943CrossRefPubMedPubMedCentral

Kleinridders, A., Ferris, H. A., Cai, W., & Kahn, C. R. (2014). Insulin action in brain regulates systemic metabolism and brain function. Diabetes, 63(7), 2232–2243. https://doi.org/10.2337/db14-0568CrossRefPubMedPubMedCentral

Laukens, K., Naulaerts, S., & Berghe, W. V. (2015). Bioinformatics approaches for the functional interpretation of protein lists: From ontology term enrichment to network analysis. Proteomics, 15(5–6), 981–996. https://doi.org/10.1002/pmic.201400296CrossRefPubMed

Leblhuber, F., Walli, J., Tilz, G. P., Wachter, H., & Fuchs, D. (1998). Systemic changes of the immune system in patients with Alzheimer's dementia. Deutsche medizinische Wochenschrift, 123(25–26), 787–791. https://doi.org/10.1055/s-2007-1024069CrossRefPubMed

Liu, Q., Zhang, Y., Wang, P., Liu, J., Li, B., Yu, Y., Wu, H., Kang, R., Zhang, X., & Wang, Z. (2019). Deciphering the scalene association among type-2 diabetes mellitus, prostate cancer, and chronic myeloid leukemia via enrichment analysis of disease-gene network. Cancer Medicine, 8(5), 2268–2277. https://doi.org/10.1002/cam4.1845CrossRefPubMedPubMedCentral

Liu, C. C., Tseng, Y. T., Li, W., Wu, C. Y., Mayzus, I., Rzhetsky, A., Sun, F., Waterman, M., Chen, J. J., Chaudhary, P. M., Loscalzo, J., Crandall, E., & Zhou, X. J. (2014). DiseaseConnect: a comprehensive web server for mechanism-based disease-disease connections. Nucleic Acids Research, 42(Web Server issue), W137–W146. https://doi.org/10.1093/nar/gku412CrossRefPubMedPubMedCentral

Lorenz, D. M., Jeng, A., & Deem, M. W. (2011). The emergence of modularity in biological systems. Physics of Life Reviews, 8(2), 129–160. https://doi.org/10.1016/j.plrev.2011.02.003CrossRefPubMedPubMedCentral

Mata, I. F., Leverenz, J. B., Weintraub, D., Trojanowski, J. Q., Hurtig, H. I., Van Deerlin, V. M., Ritz, B., Rausch, R., Rhodes, S. L., Factor, S. A., Wood-Siverio, C., Quinn, J. F., Chung, K. A., Peterson, A. L., Espay, A. J., Revilla, F. J., Devoto, J., Hu, S. C., Cholerton, B. A., … Zabetian, C. P. (2014). APOE, MAPT, and SNCA genes and cognitive performance in Parkinson disease. JAMA Neurology, 71(11), 1405–1412. https://doi.org/10.1001/jamaneurol.2014.1455CrossRefPubMedPubMedCentral

Matsuzawa, A., & Ichijo, H. (2005). Stress-responsive protein kinases in redox-regulated apoptosis signaling. Antioxidants & Redox Signaling, 7(3–4), 472–481. https://doi.org/10.1089/ars.2005.7.472CrossRef

Mazon, J. N., de Mello, A. H., Ferreira, G. K., & Rezin, G. T. (2017). The impact of obesity on neurodegenerative diseases. Life Sciences, 182, 22–28. https://doi.org/10.1016/j.lfs.2017.06.002CrossRefPubMed

McKenzie, J. A., Spielman, L. J., Pointer, C. B., Lowry, J. R., Bajwa, E., Lee, C. W., & Klegeris, A. (2017). Neuroinflammation as a common mechanism associated with the modifiable risk factors for Alzheimer’s and Parkinson’s diseases. Current Aging Science, 10(3), 158–176. https://doi.org/10.2174/1874609810666170315113244CrossRefPubMed

Miryala, S. K., Anbarasu, A., & Ramaiah, S. (2018). Discerning molecular interactions: A comprehensive review on biomolecular interaction databases and network analysis tools. Gene, 642, 84–94. https://doi.org/10.1016/j.gene.2017.11.028CrossRefPubMed

Morris, J. H., Apeltsin, L., Newman, A. M., Baumbach, J., Wittkop, T., Su, G., Bader, G. D., & Ferrin, T. E. (2011). clusterMaker: A multi-algorithm clustering plugin for Cytoscape. BMC Bioinformatics, 12, 436. https://doi.org/10.1186/1471-2105-12-436CrossRefPubMedPubMedCentral

O’Brien, J. T., & Thomas, A. (2015). Vascular dementia. Lancet (london, England), 386(10004), 1698–1706. https://doi.org/10.1016/S0140-6736(15)00463-8CrossRef

Ozawa, T., Tanaka, M., Sugiyama, S., Ino, H., Ohno, K., Hattori, K., Ohbayashi, T., Ito, T., Deguchi, H., & Kawamura, K. (1991). Patients with idiopathic cardiomyopathy belong to the same mitochondrial DNA gene family of Parkinson’s disease and mitochondrial encephalomyopathy. Biochemical and Biophysical Research Communications, 177(1), 518–525. https://doi.org/10.1016/0006-291x(91)92014-bCrossRefPubMed

Pandey, P., Pradhan, S., Modi, D. R., & Mittal, B. (2009). MTHFR and ACE gene polymorphisms and risk of vascular and degenerative dementias in the elderly. Brain and Cognition, 71(3), 295–299. https://doi.org/10.1016/j.bandc.2009.07.007CrossRefPubMed

Pereira, M. D., Ksiazek, K., & Menezes, R. (2012). Oxidative stress in neurodegenerative diseases and ageing. Oxidative Medicine and Cellular Longevity, 2012, 796360. https://doi.org/10.1155/2012/796360CrossRefPubMedPubMedCentral

Petras, M., Tatarkova, Z., Kovalska, M., Mokra, D., Dobrota, D., Lehotsky, J., & Drgova, A. (2014). Hyperhomocysteinemia as a risk factor for the neuronal system disorders. Journal of Physiology and Pharmacology : An Official Journal of the Polish Physiological Society, 65(1), 15–23.

Prentice, H., Modi, J. P., & Wu, J. Y. (2015). Mechanisms of neuronal protection against excitotoxicity, endoplasmic reticulum stress, and mitochondrial dysfunction in stroke and neurodegenerative diseases. Oxidative Medicine and Cellular Longevity, 2015, 964518. https://doi.org/10.1155/2015/964518CrossRefPubMedPubMedCentral

Prince, M. J. (2015). The global impact of dementia: an analysis of prevalence, incidence, cost and trends: Alzheimer's Disease International. World Alzheimer Report 2015.

Radi, E., Formichi, P., Battisti, C., & Federico, A. (2014). Apoptosis and oxidative stress in neurodegenerative diseases. Journal of Alzheimer’s Disease: JAD, 42(Suppl 3), S125–S152. https://doi.org/10.3233/JAD-132738CrossRefPubMed

Ramalingam, M., & Kim, S. J. (2014). Mechanisms of action of brain insulin against neurodegenerative diseases. Journal of Neural Transmission (Vienna, Austria: 1996), 121(6), 611–626. https://doi.org/10.1007/s00702-013-1147-1CrossRef

Rozycka, A., Jagodzinski, P. P., Kozubski, W., Lianeri, M., & Dorszewska, J. (2013). Homocysteine level and mechanisms of injury in Parkinson’s disease as related to MTHFR, MTR, and MTHFD1 genes polymorphisms and L-dopa treatment. Current Genomics, 14(8), 534–542. https://doi.org/10.2174/1389202914666131210210559CrossRefPubMedPubMedCentral

Sajan, M., Hansen, B., Ivey, R., 3rd., Sajan, J., Ari, C., Song, S., Braun, U., Leitges, M., Farese-Higgs, M., & Farese, R. V. (2016). Brain insulin signaling is increased in insulin-resistant states and decreases in FOXOs and PGC-1α and increases in Aβ1-40/42 and phospho-tau may abet Alzheimer development. Diabetes, 65(7), 1892–1903. https://doi.org/10.2337/db15-1428CrossRefPubMedPubMedCentral

Sanchez, P. E., Fares, R. P., Risso, J. J., Bonnet, C., Bouvard, S., Le-Cavorsin, M., Georges, B., Moulin, C., Belmeguenai, A., Bodennec, J., Morales, A., Pequignot, J. M., Baulieu, E. E., Levine, R. A., & Bezin, L. (2009). Optimal neuroprotection by erythropoietin requires elevated expression of its receptor in neurons. Proceedings of the National Academy of Sciences of the United States of America, 106(24), 9848–9853. https://doi.org/10.1073/pnas.0901840106CrossRefPubMedPubMedCentral

Santiago, J., & Hallschmid, M. (2019). Outcomes and clinical implications of intranasal insulin administration to the central nervous system. Experimental Neurology, 317, 180–190. https://doi.org/10.1016/j.expneurol.2019.03.007CrossRefPubMed

Selvaraji, S., Poh, L., Natarajan, V., Mallilankaraman, K., & Arumugam, T. V. (2019). Negative conditioning of mitochondrial dysfunction in age-related neurodegenerative diseases. Conditioning Medicine, 2(1), 30–39.PubMedPubMedCentral

Seripa, D., Matera, M. G., D’Onofrio, G., Sancarlo, D., Bizzarro, A., Cascavilla, L., Paris, F., Gravina, C., Bonghi, L., Capurso, C., Solfrizzi, V., Daniele, A., Masullo, C., Panza, F., & Pilotto, A. (2010). Polymorphism C in the serotonin transporter gene in depression-free elderly patients with vascular dementia. Dementia and Geriatric Cognitive Disorders, 29(5), 424–431. https://doi.org/10.1159/000275670CrossRefPubMed

Shabir, O., Berwick, J., & Francis, S. E. (2018). Neurovascular dysfunction in vascular dementia, Alzheimer’s and atherosclerosis. BMC Neuroscience, 19(1), 62. https://doi.org/10.1186/s12868-018-0465-5CrossRefPubMedPubMedCentral

Shefa, U., Jeong, N. Y., Song, I. O., Chung, H. J., Kim, D., Jung, J., & Huh, Y. (2019). Mitophagy links oxidative stress conditions and neurodegenerative diseases. Neural Regeneration Research, 14(5), 749–756. https://doi.org/10.4103/1673-5374.249218CrossRefPubMedPubMedCentral

Sheikh, S., Safia, H. E., & Mir, S. (2013). Neurodegenerative diseases: Multifactorial conformational diseases and their therapeutic interventions. Journal of Neurodegenerative Diseases, 2013, 563481. https://doi.org/10.1155/2013/563481CrossRefPubMed

Soul, J., Dunn, S. L., Hardingham, T. E., Boot-Handford, R. P., & Schwartz, J. M. (2016). PhenomeScape: A cytoscape app to identify differentially regulated sub-networks using known disease associations. Bioinformatics (Oxford, England), 32(24), 3847–3849. https://doi.org/10.1093/bioinformatics/btw545CrossRef

Srinivasan, V., Braidy, N., Chan, E. K., Xu, Y. H., & Chan, D. K. (2016). Genetic and environmental factors in vascular dementia: An update of blood brain barrier dysfunction. Clinical and Experimental Pharmacology & Physiology, 43(5), 515–521. https://doi.org/10.1111/1440-1681.12558CrossRef

Su, G., Kuchinsky, A., Morris, J. H., States, D. J., & Meng, F. (2010). GLay: Community structure analysis of biological networks. Bioinformatics (Oxford, England), 26(24), 3135–3137. https://doi.org/10.1093/bioinformatics/btq596CrossRef

Su, G., Morris, J. H., Demchak, B., & Bader, G. D. (2014). Biological network exploration with Cytoscape 3. Current Protocols in Bioinformatics, 47, 8.13.1-8.13.24. https://doi.org/10.1002/0471250953.bi0813s47CrossRef

Sun, M. K. (2018). Potential therapeutics for vascular cognitive impairment and dementia. Current Neuropharmacology, 16(7), 1036–1044. https://doi.org/10.2174/1570159X15666171016164734CrossRefPubMedPubMedCentral

Szklarczyk, D., Morris, J. H., Cook, H., Kuhn, M., Wyder, S., Simonovic, M., Santos, A., Doncheva, N. T., Roth, A., Bork, P., Jensen, L. J., & von Mering, C. (2017). The STRING database in 2017: Quality-controlled protein-protein association networks, made broadly accessible. Nucleic Acids Research, 45(D1), D362–D368. https://doi.org/10.1093/nar/gkw937CrossRefPubMed

Tisher, A., & Salardini, A. (2019). A comprehensive update on treatment of dementia. Seminars in Neurology, 39(2), 167–178. https://doi.org/10.1055/s-0039-1683408CrossRefPubMed

Tumminia, A., Vinciguerra, F., Parisi, M., & Frittitta, L. (2018). Type 2 diabetes mellitus and Alzheimer’s disease: role of insulin signalling and therapeutic implications. International Journal of Molecular Sciences, 19(11), 3306. https://doi.org/10.3390/ijms19113306CrossRefPubMedCentral

Ullah, R., Khan, M., Shah, S. A., Saeed, K., & Kim, M. O. (2019). Natural antioxidant anthocyanins-a hidden therapeutic candidate in metabolic disorders with major focus in neurodegeneration. Nutrients, 11(6), 1195. https://doi.org/10.3390/nu11061195CrossRefPubMedCentral

Uttara, B., Singh, A. V., Zamboni, P., & Mahajan, R. T. (2009). Oxidative stress and neurodegenerative diseases: A review of upstream and downstream antioxidant therapeutic options. Current Neuropharmacology, 7(1), 65–74. https://doi.org/10.2174/157015909787602823CrossRefPubMedPubMedCentral

Valko, M., Leibfritz, D., Moncol, J., Cronin, M. T., Mazur, M., & Telser, J. (2007). Free radicals and antioxidants in normal physiological functions and human disease. The International Journal of Biochemistry & Cell Biology, 39(1), 44–84. https://doi.org/10.1016/j.biocel.2006.07.001CrossRef

Xie, A., Gao, J., Xu, L., & Meng, D. (2014). Shared mechanisms of neurodegeneration in Alzheimer’s disease and Parkinson’s disease. BioMed Research International, 2014, 648740. https://doi.org/10.1155/2014/648740CrossRefPubMedPubMedCentral

Zhang, Y., Kong, P., Chen, Y., Yu, Y., Liu, J., Yang, L., Zhao, T., Nan, J., & Wang, Z. (2014). Significant overlapping modules and biological processes between stroke and coronary heart disease. CNS & Neurological Disorders Drug Targets, 13(4), 652–660. https://doi.org/10.2174/1871527312666131223115112CrossRef

Zhang, X., Zhang, Y., Yu, Y., Liu, J., Yuan, Y., Zhao, Y., Li, H., Wang, J., & Wang, Z. (2015). Convergence and divergence of genetic and modular networks between diabetes and breast cancer. Journal of Cellular and Molecular Medicine, 19(5), 1094–1102. https://doi.org/10.1111/jcmm.12504CrossRefPubMedPubMedCentral

Titel: Revealing the Modular Similarities and Differences Among Alzheimer’s Disease, Vascular Dementia, and Parkinson’s Disease in Genomic Networks
verfasst von: Yafei Chen
Qiong Liu
Jun Liu
Penglu Wei
Bing Li
Nongyun Wang
Zhenquan Liu
Zhong Wang
Publikationsdatum: 12.06.2021
Verlag: Springer US
Erschienen in: NeuroMolecular Medicine / Ausgabe 2/2022
Print ISSN: 1535-1084
Elektronische ISSN: 1559-1174
DOI: https://doi.org/10.1007/s12017-021-08670-2

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Demenzkranke durch Antipsychotika vielfach gefährdet

Demenz Nachrichten

Der Einsatz von Antipsychotika gegen psychische und Verhaltenssymptome in Zusammenhang mit Demenzerkrankungen erfordert eine sorgfältige Nutzen-Risiken-Abwägung. Neuen Erkenntnissen zufolge sind auf der Risikoseite weitere schwerwiegende Ereignisse zu berücksichtigen.

Nicht Creutzfeldt Jakob, sondern Abführtee-Vergiftung

29.05.2024 Hyponatriämie Nachrichten

Eine ältere Frau trinkt regelmäßig Sennesblättertee gegen ihre Verstopfung. Der scheint plötzlich gut zu wirken. Auf Durchfall und Erbrechen folgt allerdings eine Hyponatriämie. Nach deren Korrektur kommt es plötzlich zu progredienten Kognitions- und Verhaltensstörungen.

Schutz der Synapsen bei Alzheimer

29.05.2024 Morbus Alzheimer Nachrichten

Mit einem Neurotrophin-Rezeptor-Modulator lässt sich möglicherweise eine bestehende Alzheimerdemenz etwas abschwächen: Erste Phase-2-Daten deuten auf einen verbesserten Synapsenschutz.

Sozialer Aufstieg verringert Demenzgefahr

24.05.2024 Demenz Nachrichten

Ein hohes soziales Niveau ist mit die beste Versicherung gegen eine Demenz. Noch geringer ist das Demenzrisiko für Menschen, die sozial aufsteigen: Sie gewinnen fast zwei demenzfreie Lebensjahre. Umgekehrt steigt die Demenzgefahr beim sozialen Abstieg.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2022

Receptor-Interacting Protein 140 Enhanced Temozolomide-Induced Cellular Apoptosis Through Regulation of E2F1 in Human Glioma Cell Lines

Diagnostic Performance of miR-485-3p in Patients with Parkinson’s Disease and its Relationship with Neuroinflammation

Long Noncoding RNA LINC01518 Modulates Proliferation and Migration in TGF-β1-Treated Human Tenon Capsule Fibroblast Cells Through the Regulation of hsa-miR-216b-5p

Influence of Simulated Deep Brain Stimulation on the Expression of Inflammatory Mediators by Human Central Nervous System Cells In Vitro

Correction to: Receptor-Interacting Protein 140 Enhanced Temozolomide-Induced Cellular Apoptosis Through Regulation of E2F1 in Human Glioma Cell Lines